- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04694222
Use of Laser Assisted New Attachment Procedure and Low Level Laser Therapy for Periodontitis Patients (LANAP LLLT)
Evaluation of Efficacy of LANAP and Adjunctive LLLT Application in the Treatment of Periodontitis: A Randomized Controlled Clinical Study
Study Overview
Detailed Description
The study was designed as a randomized-controlled, single-blind and parallel design consisting of 80 patients with chronic periodontitis. Study consists of 4 groups, with 20 patients in each group. Group 1 received only NSPT, Group 2 received NSPT+LANAP, Group 3 received NSPT+LLLT, and Group 4 received NSPT+LANAP+LLLT. Clinical measurements of patients and gingival crevicular fluid (GCF) were taken before treatment and after 1 and 3 months. In GCF, interleukin-1beta, interleukin-10 and vascular endothelial growth factor were analyzed. Standard periapical radiographs were taken for radiographic measurements.
In moderate (4-6 mm) and deep pockets (7 mm and above), it was found that all groups treated with laser significantly decrease pocket depth (PD) and clinic attachment level (CAL) compared to Group 1. Group 3 caused significantly less gingival recession than all other groups. There was no statistical difference between the groups in biochemical markers. Radiographic analysis revealed that only Group 2 achieved significant bone filling compared to Group 1.
Bot LANAP and LLLT application in the deep pockets provide an additional contribution to NSPT. It has been found that LLLT administration leads to decrease in PD by creating a minimum recession.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Izmir, Turkey, 35000
- Katip Celebi University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- periodontitis of periodontal stage II, III, or IV with grades B
- with at least 12 teeth in the mouth and had ≥4 teeth but not all of them in the same quadrant
- with Probing depth of ≥5 mm, Clinical attachment level of ≥4 mm
- radiographic evidence of alveolar bone loss
Exclusion Criteria:
- smoking
- pregnancy and lactation
- using antibiotics in the last 6 months and anti-inflammatory drugs in the last 3rd months,
- having the systemic disease and the use of the drug that will affect the periodontal condition, having restoration of the adjacent tooth to be collected gingival crevicular fluid
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Control Group
scaling and root planning (SRP) was applied.
|
For LANAP, the fiber optic tip of the Nd:YAG laser (1064 nm) (Fotona Fidelis AT, USA) was used.
For LLLT R24 biostimulation handpiece tip (950-μm) Nd:YAG laser (1064 nm) was used.
|
ACTIVE_COMPARATOR: LANAP Group
After scaling and polishing, three LANAP stages were performed : In the first stage, Nd:YAG laser was applied.
In the second stage, full mouth SRP procedure was performed.
In the third stage, Nd:YAG laser was applied again.
|
For LANAP, the fiber optic tip of the Nd:YAG laser (1064 nm) (Fotona Fidelis AT, USA) was used.
For LLLT R24 biostimulation handpiece tip (950-μm) Nd:YAG laser (1064 nm) was used.
|
ACTIVE_COMPARATOR: LLLT Group
after SRP Low Level Laser Therapy was performed using Nd:YAG laser.
|
For LANAP, the fiber optic tip of the Nd:YAG laser (1064 nm) (Fotona Fidelis AT, USA) was used.
For LLLT R24 biostimulation handpiece tip (950-μm) Nd:YAG laser (1064 nm) was used.
|
ACTIVE_COMPARATOR: LANAP+LLLT Group
after scaling both LANAP and LLLT were applied.
|
For LANAP, the fiber optic tip of the Nd:YAG laser (1064 nm) (Fotona Fidelis AT, USA) was used.
For LLLT R24 biostimulation handpiece tip (950-μm) Nd:YAG laser (1064 nm) was used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical attachment level gain
Time Frame: Baseline
|
The clinical attachment level is determined by measuring the distance from the cemento-enamel junction to the gingival margin and adding the pocket depth to it.
|
Baseline
|
Clinical attachment level gain
Time Frame: 1 month
|
The clinical attachment level is determined by measuring the distance from the cemento-enamel junction to the gingival margin and adding the pocket depth to it.
|
1 month
|
Clinical attachment level gain
Time Frame: 3 month
|
The clinical attachment level is determined by measuring the distance from the cemento-enamel junction to the gingival margin and adding the pocket depth to it.
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Probing depth
Time Frame: Baseline
|
It is determined by measuring the distance from the gingival margin to the pocket base
|
Baseline
|
Probing depth
Time Frame: 1 Month
|
It is determined by measuring the distance from the gingival margin to the pocket base
|
1 Month
|
Probing depth
Time Frame: 3 Month
|
It is determined by measuring the distance from the gingival margin to the pocket base
|
3 Month
|
Gingival index
Time Frame: Baseline
|
For assessing severity of gingivitis, and its location by examining qualitative changes of gingival tissues
|
Baseline
|
Gingival index
Time Frame: 1 Month
|
For assessing severity of gingivitis, and its location by examining qualitative changes of gingival tissues
|
1 Month
|
Gingival index
Time Frame: 3 Month
|
For assessing severity of gingivitis, and its location by examining qualitative changes of gingival tissues
|
3 Month
|
Plaque index
Time Frame: Baseline
|
This index measures the thickness of plaque on gingival one third
|
Baseline
|
Plaque index
Time Frame: 1 Month
|
This index measures the thickness of plaque on gingival one third
|
1 Month
|
Plaque index
Time Frame: 3 Month
|
This index measures the thickness of plaque on gingival one third
|
3 Month
|
Bleeding on probing
Time Frame: Baseline
|
In this index, probing is performed by gently walking around the pocket and bleeding is evaluated.
As a result of probing, evaluation is made by looking at the presence or absence of bleeding in the gingiva.
|
Baseline
|
Bleeding on probing
Time Frame: 1 Month
|
In this index, probing is performed by gently walking around the pocket and bleeding is evaluated.
As a result of probing, evaluation is made by looking at the presence or absence of bleeding in the gingiva.
|
1 Month
|
Bleeding on probing
Time Frame: 3 Month
|
In this index, probing is performed by gently walking around the pocket and bleeding is evaluated.
As a result of probing, evaluation is made by looking at the presence or absence of bleeding in the gingiva.
|
3 Month
|
Interleukin-1beta
Time Frame: Baseline
|
IL-1 is a protein produced mainly by monocytes and macrophages as a polyclonal activator.
|
Baseline
|
Interleukin-1beta
Time Frame: 1 Month
|
IL-1 is a protein produced mainly by monocytes and macrophages as a polyclonal activator.
|
1 Month
|
Interleukin-1beta
Time Frame: 3 Month
|
IL-1 is a protein produced mainly by monocytes and macrophages as a polyclonal activator.
|
3 Month
|
Interleukin-10
Time Frame: Baseline
|
IL-10 is an 18 kilodalton (KD) cytokine with a wide variety of (pleiotropic) effects.
|
Baseline
|
Interleukin-10
Time Frame: 1 Month
|
IL-10 is an 18 kilodalton (KD) cytokine with a wide variety of (pleiotropic) effects.
|
1 Month
|
Interleukin-10
Time Frame: 3 Month
|
IL-10 is an 18 kilodalton (KD) cytokine with a wide variety of (pleiotropic) effects.
|
3 Month
|
vascular endothelial growth factor (VEGF)
Time Frame: Baseline
|
VEGF is a glycoprotein molecule that is a potential stimulator of angiogenesis.
|
Baseline
|
vascular endothelial growth factor (VEGF)
Time Frame: 1 Month
|
VEGF is a glycoprotein molecule that is a potential stimulator of angiogenesis.
|
1 Month
|
vascular endothelial growth factor (VEGF)
Time Frame: 3 Month
|
VEGF is a glycoprotein molecule that is a potential stimulator of angiogenesis.
|
3 Month
|
Radiographic bone fill
Time Frame: Baseline
|
The effects of treatments on bone loss were evaluated by making some measurements on periapical radiography.
|
Baseline
|
Radiographic bone fill
Time Frame: 1 Month
|
The effects of treatments on bone loss were evaluated by making some measurements on periapical radiography.
|
1 Month
|
Radiographic bone fill
Time Frame: 3 Month
|
The effects of treatments on bone loss were evaluated by making some measurements on periapical radiography.
|
3 Month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Serhat Köseoğlu, Study Manager
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-TDU-DİŞF-0040
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
Panineeya Mahavidyalaya Institute of Dental Sciences...Research Institute for Genetic and Human TherapyUnknownGeneralized Adult Periodontitis
-
Asem Mohammed Kamel AliCompletedMolar-incisor Pattern Grade C Periodontitis ( Localized Aggressive Periodontitis) | Generalized Grade C Periodontitis (Generalized Aggressive Periodontitis)Egypt
-
Columbia UniversityCompletedPeriodontal Diseases | Generalized Moderate Chronic Periodontitis | Generalized Severe Chronic PeriodontitisUnited States
-
Postgraduate Institute of Dental Sciences RohtakUnknownChronic Apical PeriodontitisIndia
-
University of SienaNot yet recruitingPeriodontitis, AdultItaly
-
Lithuanian University of Health SciencesCompleted
-
Louisiana State University Health Sciences Center...CompletedPeriodontitis, AdultUnited States
-
University of BergenCompletedPeriodontitis | Adult Periodontitis
-
Cairo UniversityUnknownPeriodontitis, AdultEgypt
Clinical Trials on Nd:YAG laser
-
Henry Ford Health SystemCompletedHidradenitis SuppurativaUnited States
-
University of GaziantepCompleted
-
Sohag UniversityRecruitingPosterior Capsule OpacificationEgypt
-
Credit Valley EyeCareCompletedNarrow Angle Patients at Risk for Angle Closure GlaucomaCanada
-
Cynosure, Inc.CompletedHYPERHIDROSISUnited States
-
University of California, San DiegoMassachusetts General HospitalCompletedBasal Cell CarcinomaUnited States
-
Université de SherbrookeCentre de recherche du Centre hospitalier universitaire de Sherbrooke; Exog...Completed
-
Mahidol UniversityUnknownBenign Pigmented LesionsThailand
-
Tanta UniversityCompletedProliferative Diabetic Retinopathy